Regarding the immune microenvironment, a reduction in CD8+ Tex is consistently observed across PC-, LC-, and BC-BoM; whereas a reduction in CD8+ Tcm commonly occurs in PC- and LC-BoM. This evidence concerns the gene CD8A and breast cancer.